Express Scripts Holding Company (ESRX) Shares Sold by Davidson & Garrard Inc.
Davidson & Garrard Inc. decreased its position in shares of Express Scripts Holding Company (NASDAQ:ESRX) by 11.9% during the second quarter, according to its most recent filing with the SEC. The firm owned 27,910 shares of the company’s stock after selling 3,770 shares during the period. Davidson & Garrard Inc.’s holdings in Express Scripts Holding were worth $1,782,000 at the end of the most recent quarter.
Other hedge funds have also recently bought and sold shares of the company. Burt Wealth Advisors grew its holdings in shares of Express Scripts Holding by 11.4% during the 2nd quarter. Burt Wealth Advisors now owns 1,696 shares of the company’s stock worth $108,000 after acquiring an additional 174 shares during the period. CKW Financial Group grew its holdings in shares of Express Scripts Holding by 20.0% during the 2nd quarter. CKW Financial Group now owns 1,800 shares of the company’s stock worth $115,000 after acquiring an additional 300 shares during the period. TrimTabs Asset Management LLC purchased a new position in shares of Express Scripts Holding during the 1st quarter worth approximately $121,000. Capital Analysts LLC grew its holdings in shares of Express Scripts Holding by 5.6% during the 1st quarter. Capital Analysts LLC now owns 1,877 shares of the company’s stock worth $124,000 after acquiring an additional 100 shares during the period. Finally, IHT Wealth Management LLC grew its holdings in shares of Express Scripts Holding by 8.1% during the 1st quarter. IHT Wealth Management LLC now owns 1,944 shares of the company’s stock worth $128,000 after acquiring an additional 145 shares during the period. Hedge funds and other institutional investors own 88.69% of the company’s stock.
Express Scripts Holding Company (NASDAQ ESRX) opened at 62.01 on Tuesday. Express Scripts Holding Company has a 52-week low of $57.80 and a 52-week high of $77.50. The company has a market capitalization of $35.81 billion, a PE ratio of 10.76 and a beta of 0.88. The company has a 50-day moving average price of $61.86 and a 200 day moving average price of $63.04.
Express Scripts Holding (NASDAQ:ESRX) last released its quarterly earnings results on Tuesday, July 25th. The company reported $1.73 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $1.71 by $0.02. Express Scripts Holding had a net margin of 3.50% and a return on equity of 25.58%. The business had revenue of $25.35 billion for the quarter, compared to analyst estimates of $25.52 billion. During the same period in the previous year, the company earned $1.57 earnings per share. The business’s revenue for the quarter was up .5% on a year-over-year basis. Equities research analysts anticipate that Express Scripts Holding Company will post $6.99 earnings per share for the current year.
In other Express Scripts Holding news, VP Everett Neville sold 1,163 shares of Express Scripts Holding stock in a transaction on Wednesday, August 23rd. The shares were sold at an average price of $61.48, for a total value of $71,501.24. Following the transaction, the vice president now directly owns 18,232 shares of the company’s stock, valued at $1,120,903.36. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Woodrow A. Myers, Jr. sold 3,900 shares of Express Scripts Holding stock in a transaction on Monday, September 11th. The stock was sold at an average price of $63.93, for a total transaction of $249,327.00. Following the completion of the transaction, the director now directly owns 11,500 shares in the company, valued at $735,195. The disclosure for this sale can be found here. Insiders sold 5,641 shares of company stock worth $357,317 over the last ninety days. Corporate insiders own 0.68% of the company’s stock.
ESRX has been the topic of a number of research analyst reports. Jefferies Group LLC set a $72.00 target price on Express Scripts Holding and gave the stock a “buy” rating in a report on Tuesday, August 29th. ValuEngine downgraded Express Scripts Holding from a “buy” rating to a “hold” rating in a report on Friday, September 1st. Robert W. Baird reiterated a “hold” rating and set a $56.00 target price on shares of Express Scripts Holding in a report on Friday, September 1st. Needham & Company LLC initiated coverage on Express Scripts Holding in a report on Friday, July 21st. They set a “hold” rating on the stock. Finally, BidaskClub upgraded Express Scripts Holding from a “sell” rating to a “hold” rating in a report on Saturday, June 17th. Four investment analysts have rated the stock with a sell rating, thirteen have given a hold rating, five have issued a buy rating and one has assigned a strong buy rating to the company’s stock. The stock currently has a consensus rating of “Hold” and a consensus price target of $70.24.
TRADEMARK VIOLATION NOTICE: “Express Scripts Holding Company (ESRX) Shares Sold by Davidson & Garrard Inc.” was posted by The Cerbat Gem and is owned by of The Cerbat Gem. If you are viewing this story on another site, it was copied illegally and republished in violation of US and international trademark & copyright law. The correct version of this story can be read at https://www.thecerbatgem.com/2017/09/19/express-scripts-holding-company-esrx-shares-sold-by-davidson-garrard-inc.html.
About Express Scripts Holding
Express Scripts, Inc is a pharmacy benefit management (PBM) company in North America, offering a range of services to its clients, which include health insurers, third-party administrators, employers, union-sponsored benefit plans, workers’ compensation plans and government health programs. It operates in two segments: PBM and Emerging Markets (EM).
Receive News & Stock Ratings for Express Scripts Holding Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Express Scripts Holding Company and related stocks with our FREE daily email newsletter.